Norris Medicines share price

ABOUT Norris Medicines

• Industry Biotechnology & Drugs
• ISIN INE744C01029
• BSE Code 524414
• NSE Code -

Norris Medicines Limited is an India-based company, which is focused on the health care industry. It also focused on manufacturing of injections and medicinal formulations. It is engaged in carrying out contract manufacturing and loan license manufacturing for large multinational and big Indian pharma companies. It offers Antibiotic Range, Antiinflammatory / Pain Management, Anti-Emetic, Nutrition, Cough/Cold, Skin & Allergy, Anti-Malaria and other products. Its Antibiotic product range includes Arizon-100, Arizon-250, Arizon-500, Cefan-dry syurp, Cefan DT-50, Cefan DT-100, Cefan DT-200, and others. Its Anti-Emetic products include Onvin Syrup and Onvin. Nutrition products include Can-D XP, Cand Fort, Hemfit Plus Syrup, Hemfit-Z, and others. Its Anti-Malaria products include Antimal DT-20, Antimal DT-80, Antimal Dry Syrup and Antimal. Its Diabeticals Cardiac products include Amlonor-5, Amlonor-A, Atvinor-10, Enorpril-2.5, Enorpril-5, Lostinor-25, Raminor-5, Glynor-MF and others.

Norris Medicines Management

• Iqubal Patel Chief Financial Officer
• Vimal Shah Managing Director, Executive Director
• Priyanka Lohiya Company Secretary